Cargando…

Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study

Calcineurin inhibitors, including tacrolimus, are largely responsible for advances in allotransplantation. However, the nephrotoxicity associated with these immunosuppressants impairs patients' long-term survival after renal allograft. Therefore, novel regimens that minimize or even eliminate c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Guang-hui, Chen, Zheng, Xu, Lu, Zhu, Jing-hui, Xiang, Peng, Ma, Jun-jie, Peng, Yan-wen, Li, Guang-hui, Chen, Xiao-yong, Fang, Jia-li, Guo, Yu-he, Zhang, Lei, Liu, Long-shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper: Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914271/ https://www.ncbi.nlm.nih.gov/pubmed/26933811 http://dx.doi.org/10.18632/oncotarget.7725

Ejemplares similares

Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation
por: Ding, Chen-Guang, et al.
Publicado: (2018)

Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2017)

Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
por: Verneuil, Laurence, et al.
Publicado: (2015)

Predictors of Short-Term Outcomes in Living Donor Renal Allograft Recipients: A Prospective Study From a Tertiary Care Center in North India
por: John, Elenjickal Elias, et al.
Publicado: (2022)

Corrigendum: Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2018)

Acute Lymphoblastic Leukemia in an Adult After Renal Transplantation
por: Khan, Farhana Yaqoob, et al.
Publicado: (2022)

Papillary Renal Cell Carcinomas Demonstrating Micropapillary Features: An Investigation Into the Diagnostic and Prognostic Implications
por: Caraballo, Beatriz, et al.
Publicado: (2022)

Beneficial Effect of Moderately Increasing Hypothermic Machine Perfusion Pressure on Donor after Cardiac Death Renal Transplantation
por: Ding, Chen-Guang, et al.
Publicado: (2018)

The Severity of Interstitial Inflammation in the Renal Parenchyma of Albino Rats Is Subjected to the Dose of Heavy Metals
por: Kareem, Hira, et al.
Publicado: (2022)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
por: Qu, Lihui, et al.
Publicado: (2017)

Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
por: von Einsiedel, Johannes, et al.
Publicado: (2020)

Hemophagocytic Syndrome-Associated Intravascular Large B-cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease Treated With Autologous Stem Cell Transplantation Using a Modified TEAM Regimen
por: Kama, Kudret, et al.
Publicado: (2022)

Blood Group Discrepancy in a Whole Blood Donor With Weak AB
por: Wasnik, Minal, et al.
Publicado: (2023)

Genetic factors underlying tacrolimus intolerance after liver transplantation
por: Liu, Yuan, et al.
Publicado: (2022)

Transplantation of induced mesenchymal stem cells for treating chronic renal insufficiency
por: Pan, Xing-hua, et al.
Publicado: (2017)

A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients
por: Tang, Jiang-Tao, et al.
Publicado: (2018)

Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
por: Qu, Lihui, et al.
Publicado: (2020)

Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
por: Lee, John R., et al.
Publicado: (2015)

Individualized Dosage of Tacrolimus for Renal Transplantation Patients Based on Pharmacometabonomics
por: He, Xiaoying, et al.
Publicado: (2022)

Spindle Cell Renal Neoplasms: A Pathological Case Report on Primary Renal Leiomyosarcoma and Sarcomatoid Renal Cell Carcinoma
por: Popov, Hristo, et al.
Publicado: (2023)

Revisit of Polyomavirus Nephropathy Grading in Renal Allograft Recipients According to the Banff 2019 Working Group Classification: A Study From a Large Transplant Center in South India
por: Subramanian, Kalaivani S, et al.
Publicado: (2022)

Nonneoplastic Renal Parenchymal Changes in Renal Cell Carcinoma With Tumor Thrombus
por: Farag, Ahmed, et al.
Publicado: (2021)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
por: SHAN, GUANG, et al.
Publicado: (2016)

The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy
por: Chen, Xu-Tao, et al.
Publicado: (2019)

Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis
por: Gao, Wen-hui, et al.
Publicado: (2023)

Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients
por: Qian, Zhiyu, et al.
Publicado: (2022)

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
por: Francke, Marith I., et al.
Publicado: (2021)

FLT3-ITD Mutation and Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Case Study
por: Saeed, Shahzeb, et al.
Publicado: (2023)

A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study
por: Yan, Tian-zhong, et al.
Publicado: (2016)

Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma
por: Kalita, Pranjal, et al.
Publicado: (2023)

Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation
por: Chen, Yi-kuan, et al.
Publicado: (2014)

In vivo regeneration of renal vessels post whole decellularized kidneys transplantation
por: Zhang, JianSe, et al.
Publicado: (2015)

Concurrent leukoencephalomyelitis and polyneuritis in a Maltese terrier: resembling combined central and peripheral demyelination in humans
por: LI, Wen-Ta, et al.
Publicado: (2019)

The effects of high glucose on tendon-derived stem cells: implications of the pathogenesis of diabetic tendon disorders
por: Lin, Yu-Cheng, et al.
Publicado: (2017)

Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation
por: Unagami, Kohei, et al.
Publicado: (2020)

Phosphaturic Mesenchymal Tumor: A Case Report of a Rare Entity
por: Hudairy, Rawan E, et al.
Publicado: (2022)

A retrospective analysis of the safety and efficacy of low dose tacrolimus (FK506) for living donor liver transplant recipients
por: Wu, Zhengshan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d53qanchuon9m8ipt2g6d0bpn6